Biopure Case Study Executive Summary * Biopure Corporation developed two new products to enter into the field of blood substitutes: Hemopure‚ directed to the human market and Oxyglobin‚ for the veterinary market. Through the end of 1997 no blood substitute had received approval for use anywhere in the world. * What distinguishes both products from other “hemoglobin-based” blood substitutes is the fact that they are “bovine-sourced” as opposed to “human-sourced”‚ i.e. they are derived from
Free Blood Blood transfusion
BIOPURE Corporation. 1. Give your best estimate of the sizes of Biopure’s market‚ potential market‚ and what you recommend as the target market in the animal market? Do the same for the human blood market? Who are these people (or animals)? Since the definitions of these different markets can be vague‚ it may be useful to operationalize these concepts in terms of circles on a target which represent the likelihood of being a customer and when they should be targeted by the company. Thus‚ the “target
Free Blood Blood transfusion Surgery
Andrew Walters 3/22/12 Biopure Biopure Corporation specializes in blood substitutes for transfusion patients‚ both in the veterinary market and the human market. However‚ in 1998‚ Biopure faced the monumental decision of whether to begin selling Oxyglobin‚ a blood substitute‚ to the veterinary market or to wait until Hemoglobin‚ a blood substitute for the human market‚ became available for sale. The problem is whether or not the company should launch Oxyglobin before Hemoglobin is FDA-approved
Premium Blood transfusion Blood
BIOPURE CASE SUMMARY Course: Strategic Marketing Management Name: Firat Sekerli The Problem: Biopure Corporation has two new products that are Oxyglobin and Hemopure. Oxyglobin is the first new blood substitute for the veterinary market and is ready for consumer use. Hemopure is another new blood substitute for the human market and it will take two years to launch the product from now on. Ted Jacobs‚ vice president for Human Clinical
Premium Marketing Blood transfusion Blood
INTRODUCTION In the case of Biopure‚ the issue is to decide whether to launch Oxyglobin and how to launch it without jeopardizing the potential of Hemopure. Oxyglobin is a substitute to animal blood while Hemopure is a substitute to human blood. The CEO need to identify the influence of the launch of Oxyglobin bring to Hemopure. If the company is launching Oxyglobin‚ the CEO need to decide the price‚ identify the target client‚ choose distributing method and consider the production capacity. The
Free Blood Blood transfusion Veterinary medicine
McDonald’s Corporation Case Analysis Name left out BUSN 412 Business Policy July 27‚ 2008 CASE ANALYSIS MCDONALD’S CORPORATION COMPANY NAME: McDonald’s Corporation INDUSTRY: Fast Food COMPANY WEB SITE: http://www.McDonald’s.com/corp.html COMPANY BACKGROUND: The first McDonald’s was built in 1940 by the brothers Dick and Mac McDonald. In 1954 Ray Kroc became the first franchisee appointed by Mac and Dick McDonald in San Bernardino‚ California. The following year‚ 1955‚ Kroc opened his
Premium Hamburger
2010-2011 MASSEY UNIVERSITY Honesty Declaration School of Management (Albany) |Lecturer’s Name |Paper Name |Paper Number | |David Tappin |Project Management |152.752 | Honesty Declaration |I/we declare that this is an original assignment and is entirely my/our own work.
Premium Project management Management
HERNISCHFEGER CORPORATION CASE ANALYSIS 1. Describe clearly the accounting changes Harnischfeger made in 1984 as stated in Note 2 of its financial statements In 1984 they changed the depreciation method from accelerated methods to the straight-line for financial reporting purposes. This change included a adjustment of the residual values on certain machinery and equipment. They also included the products purchased from Kobe Steel‚ LTD and sold by them in their net sales. Moreover‚ they
Premium Depreciation Income statement Pension
Financial Decision Making Final Project Case analysis: Marriott Corporation Introduction and background The Marriott Corporation‚ an American firm‚ was founded in 1927 by J.Willard Marriot.The company began as a small beer stand and soon began to sell food and provided lodging that expanded rapidly. With the help of his wife Alice‚ the family owned business had 45 restaurants in nine states by 1940 and grew into one of the leading service companies. The Company has three major lines
Premium Rate of return Net present value Weighted average cost of capital
Sony Corporation Time Context: End of the fiscal year in March 2000 Viewpoint: Marketing Analyst Facts: March‚ 2000 - Sony Corporation began to redesign itself as a forward-looking company in the network era of the 21st century. Consolidated net sales in the given fiscal year: 6‚687 billion yen Operating income: 241 billion yen Sony’s market capitalization: 9.1 trillion yen 4th among the Japanese companies listed on the Tokyo Stock Exchange as of May 18 2001 (Top 3 companies- NTT Docomo‚
Premium Sony